Blood transfusion devices market seen growing to $7.55 billion by 2030

The blood transfusion devices market is projected to rise from $5.45 billion in 2025 to $7.55 billion by 2030, driven by more trauma cases, surgeries, hospital expansion and tighter safety rules. North America led the market in 2025, while the report points to faster growth in Asia-Pacific and new demand for automated and digitally monitored systems.

Why it matters: - Blood transfusion devices support life-saving care in trauma, surgery and treatment for conditions such as anemia and clotting disorders. - The market’s growth signals rising demand for safer, faster blood transfer in hospitals, blood banks and emergency settings. - Expansion in automated systems and digital tracking could improve transfusion precision and safety.

What happened: - The Business Research Company released a global blood transfusion devices market report on July 29, 2026. - The report says the market will grow from $5.45 billion in 2025 to $5.84 billion in 2026. - The report forecasts the market will reach $7.55 billion by 2030. - North America held the largest share of the market in 2025. - The report covers North America, Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

The details: - The report describes blood transfusion devices as instruments and equipment used to transfer blood or blood components from donors to recipients. - The devices are used for red blood cells, plasma and platelets. - The report links growth to continued reliance on manual transfusion techniques and limited availability of advanced pathogen reduction systems. - Rising surgical volumes, expansion of hospital and blood bank infrastructure, and greater awareness of transfusion safety are also listed as growth drivers. - The report highlights innovation in automated apheresis and blood component separation. - The report points to growth in minimally invasive surgeries, blood bank networks, stricter regulations, smart monitoring and digital tracking. - Emerging trends include automated blood component separation systems, pathogen reduction technologies, new blood bags and accessories, specialized venous access devices, and more blood storage and transfusion equipment. - A free sample of the report is available here. - The full report is available here.

Between the lines: - Trauma and accident cases remain a major demand driver because blood transfusion devices can rapidly deliver blood products to stabilize severe bleeding. - The release cites National Safety Council Injury Facts showing US motor-vehicle fatalities reached 20,900 in the first half of 2024, nearly matching 20,930 in the same period of 2023. - Those deaths came despite a 0.8% increase in mileage from 2023 and a 3.1% rise from 2022. - The regional split suggests mature markets such as North America still dominate, while Asia-Pacific has room to catch up as healthcare capacity expands. - The report’s focus on digital monitoring and forecasting tools reflects a broader shift toward more data-driven medical supply chains.

What's next: - The market is projected to grow at a 6.7% CAGR from 2026 to 2030. - Further adoption of automated apheresis, pathogen reduction and digital tracking should shape product development. - More hospital spending, blood bank expansion and regulatory tightening are likely to keep pressure on manufacturers to improve safety and efficiency. - The report says new 2026 editions will add market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics and future trend analysis.

The bottom line: - Blood transfusion devices are moving from a steady-growth niche into a more technology-driven market, with safety, automation and trauma demand setting the pace.